Furthermore, in a previous study on CRC, we showed the potential of Calebin A on suppressing-TNF-β-induced inflammatory signaling, blocking proliferation, migration and invasion of CRC cells [18], emphasizing the promising of natural substances on targeting TNF-β/NF-κB signaling axis. The gene discussed is NFKB1; the disease is colorectal carcinoma.